Any current/future new fundraising through debt or equity?

The transcript does not mention any current or planned fundraising through debt or equity. The company highlights disciplined capital allocation with Capex guidance of ₹250 crore in FY26 and ₹200 crore in FY27. They mention operating with a strong balance sheet and maintaining net cash of ₹355 crore. The focus is on internal funding through strong cash flows and disciplined Capex rather than raising external funds. No specific plans for issuing new debt or equity were disclosed during the Q3FY26 earnings call.

Any current/future capex/capital investment/strategic investment?

Ellenbarrie is undertaking three main projects with a total capex of about ₹450 crores over the next couple of years. Projects include an on-site plant in Eastern India, a merchant plant in Northern India, and a merchant plus specialty gases plant in Western India. The Eastern India on-site plant is expected to be commissioned in Q1 FY27. The Northern India merchant plant is targeted for commissioning in H2 FY27. The Western India specialty gases and merchant plant is expected by FY28. Capex guidance is ₹250 crores in FY26 and ₹200 crores in FY27. Expansion focuses primarily on basic air gases

Future growth expectations in sales/revenue/volumes?

Company targets a long-term revenue growth rate of about 20-25% CAGR. Growth will be lumpy, driven by step changes as new capacity plants are commissioned. New plants coming online: Uluberia 2 merchant plant recently commissioned; East India on-site plant expected Q1 FY27; North India bulk plant expected H2 FY27; Western India speciality gases unit targeted FY28. Uluberia 2 ramp-up expected to reach 85% capacity utilization faster than typical 18 months due to existing market presence. Expansion projects totaling around INR 450 crore capex over next couple of years. Long-term growth is tied to

Future growth expectations in earnings/operating earnings/profits/EPS?

Ellenbarrie Industrial Gases Ltd targets a long-term revenue CAGR of 20-25%, driven by new capacity additions across Eastern, Northern, and Western India over FY27-FY28. New plants: On-site plant in East India (Q1 FY27), North India bulk plant (H2 FY27), and Western India specialty gases facility (FY28) are expected to boost growth. EBITDA margins aim to improve from the current mid-30% range to around 40% long-term, aided by newer, more energy-efficient plants and normalization of Argon prices. Q4 FY26 is anticipated to show improved performance compared to Q3, owing to capacity ramp-up

Current/ Expected Orderbook/ Pending Orders?

Ellenbarrie Industrial Gases Ltd has ordered new plants as part of their expansion. The North India merchant plant commissioning timeline is set for H2 FY27. Plant orders have been placed, with construction and civil work scheduled around equipment delivery. No specific quantitative details on the total current or pending order book were disclosed. The company's growth focus includes three key projects: an on-site plant in Eastern India (expected Q1 FY27), a North India merchant plant (H2 FY27), and a Western India merchant plus specialty gases plant (target FY28). Capex for these projects is

IN US

Sale is live|00:00:00left today

Ellenbarrie Industrial Gases LtdQ4 FY27Chemicals & Petrochemicals

Ellenbarrie Industrial Gases Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹276P/E: 38.9Market Cap: ₹3.9K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→Company targets a long-term revenue growth rate of about 20-25% CAGR.
→Growth will be lumpy, driven by step changes as new capacity plants are commissioned.
→New plants coming online: Uluberia 2 merchant plant recently commissioned; East India on-site plant expected Q1 FY27; North India bulk plant expected H2 FY27; Western India speciality gases unit targeted FY28.
→Uluberia 2 ramp-up expected to reach 85% capacity utilization faster than typical 18 months due to existing market presence.
→Expansion projects totaling around INR 450 crore capex over next couple of years.
→Long-term growth is tied to both organic capacity increase and entering speciality gases (e.g., solar industry).
→Current capacity utilization is high; future expansion primarily via greenfield plants.
→Short-term revenue guidance not provided; emphasis on long-term sustained growth trajectory.

Margin guidance

Category 1

→Ellenbarrie Industrial Gases Ltd targets a long-term revenue CAGR of 20-25%, driven by new capacity additions across Eastern, Northern, and Western India over FY27-FY28.
→New plants: On-site plant in East India (Q1 FY27), North India bulk plant (H2 FY27), and Western India specialty gases facility (FY28) are expected to boost growth.
→EBITDA margins aim to improve from the current mid-30% range to around 40% long-term, aided by newer, more energy-efficient plants and normalization of Argon prices.
→Q4 FY26 is anticipated to show improved performance compared to Q3, owing to capacity ramp-up.
→Growth is projected to be lumpy, corresponding with commissioning of new plants rather than smooth quarter-on-quarter increments.
→The company remains cautious about short-term guidance but confident about its upward earnings trajectory, driven by capacity expansions and sector recovery.

3 more insights locked — sign up free to unlock

Fundraise plans

→The transcript does not mention any current or planned fundraising through debt or equity.
→The company highlights disciplined capital allocation with Capex guidance of ₹250 crore in FY26 and ₹200 crore in FY27.
→They mention operating with a strong balance sheet and maintaining net cash of ₹355 crore.
→The focus is on internal funding through strong cash flows and disciplined Capex rather than raising external funds.
→No specific plans for issuing new debt or equity were disclosed during the Q3FY26 earnings call.

Order book

→Ellenbarrie Industrial Gases Ltd has ordered new plants as part of their expansion.
→The North India merchant plant commissioning timeline is set for H2 FY27.
→Plant orders have been placed, with construction and civil work scheduled around equipment delivery.
→No specific quantitative details on the total current or pending order book were disclosed.
→The company's growth focus includes three key projects: an on-site plant in Eastern India (expected Q1 FY27), a North India merchant plant (H2 FY27), and a Western India merchant plus specialty gases plant (target FY28).
→Capex for these projects is around Rs. 450 crore over the next couple of years.
→The company emphasizes long-term growth and capacity additions rather than quarterly order book specifics.

Capex plans

Yes

→Ellenbarrie is undertaking three main projects with a total capex of about ₹450 crores over the next couple of years.
→Projects include an on-site plant in Eastern India, a merchant plant in Northern India, and a merchant plus specialty gases plant in Western India.
→The Eastern India on-site plant is expected to be commissioned in Q1 FY27.
→The Northern India merchant plant is targeted for commissioning in H2 FY27.
→The Western India specialty gases and merchant plant is expected by FY28.
→Capex guidance is ₹250 crores in FY26 and ₹200 crores in FY27.
→Expansion focuses primarily on basic air gases (oxygen, nitrogen, argon) and increasing portfolio in specialty gases used in solar industry.
→The company is also working on power cost optimization via renewable energy contracts.

How does Ellenbarrie Industrial Gases Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Ellenbarrie Industrial Gases Ltd

Rev 2Mar 1

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Ellenbarrie Industrial Gases Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio